Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-331,070
Closed -$13M 29
2016
Q2
$13M Buy
331,070
+20,690
+7% +$824K 0.57% 40
2016
Q1
$13M Sell
310,380
-30,294
-9% -$1.2M 0.49% 54
2015
Q4
$15.3M Buy
340,674
+130,674
+62% +$5.77M 0.47% 67
2015
Q3
$8.45M Sell
210,000
-67,680
-24% -$3.19M 0.38% 98
2015
Q2
$13.6M Sell
277,680
-440,390
-61% -$21.1M 0.27% 122
2015
Q1
$33.3M Buy
718,070
+462,070
+180% +$21.2M 0.61% 39
2014
Q4
$11.5M Sell
256,000
-676,380
-73% -$29.5M 0.11% 191
2014
Q3
$38.8M Buy
932,380
+24,650
+3% +$1.04M 0.28% 80
2014
Q2
$37.1M Sell
907,730
-119,194
-12% -$4.68M 0.26% 91
2014
Q1
$39.5M Buy
1,026,924
+172,060
+20% +$6.63M 0.3% 74
2013
Q4
$32.8M Sell
854,864
-27,140
-3% -$1M 0.27% 79
2013
Q3
$29.3M Buy
882,004
+144,754
+20% +$5.08M 0.3% 78
2013
Q2
$25.7M Buy
+737,250
New +$27M 0.32% 72

Other funds holding ABT

Euclid Advisors's ABT Position: Q3 2016 in Review

Euclid Advisors sold out of Abbott (ABT) in Q3 2016, closing a stake of 331,070 shares — an estimated $13M sold.

Euclid Advisors first reported a position in ABT in Q2 2013 and held it in 13 quarters. The position peaked at $39.5M in Q1 2014. 1,496 funds tracked by Wall St. Rank hold ABT as of Q3 2016.

  • Euclid Advisors reported no remaining Abbott position as of Q3 2016 after selling out during the quarter.
  • Euclid Advisors sold 331,070 Abbott shares in Q3 2016, an estimated $13M.
  • Euclid Advisors first reported a position in Abbott in Q2 2013 and held it in 13 quarters.
  • Euclid Advisors's Abbott position peaked at $39.5M in Q1 2014.
  • 1,496 funds tracked by Wall St. Rank held Abbott as of Q3 2016.

Based on Euclid Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.